http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_795dd9ae7a27cf1e949e86ef5638103e
Outgoing Links
Predicate | Object |
---|---|
family-name | Green |
name | Anthony R. Green Anthony R Green |
given-name | Anthony R. Anthony R |
organization-name | Department of Hematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 2XY Department of Hematology, Cambridge Institute for Medical Research, University of Cambridge, Addenbrookes Hospital, Cambridge CB2 2XY, United Kingdom; The Sanger Centre, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1RQ, United Kingdom; and Institute of Genetics, University of Nottingham, Queens Medical Centre, Nottingham NG7 2UH, United Kingdom University of Cambridge Cambridge UK Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom;; Wellcome MRC Cambridge Stem Cell Institute and; Department of Haematology, University of Cambridge, Cambridge, United Kingdom; From the University of Cambridge, Department of Haematology, Cambridge Institute for Medical Research, Hills Road, Cambridge, CB2 2XY, United Kingdom. From the Wellcome–MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., C.E.M., F.L.N., A.R.G., P.J.C.), the Department of Haematology, University of Cambridge (J.G., E.J.B., C.M., J.C., C.E.M., F.L.N., A.R.G.), and the Department of Haematology, Cambridge University Hospitals NHS Foundation Trust (J.G., E.J.B., A.L.G., C.M., J.C., A.R.G.), Cambridge, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus (J.N., D.C.W., N.A., E.P., G.G., L.O., S.O., J.W.T., A.P.B.,... Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom Cambridge Institute for Medical Research Wellcome Trust/MRC Stem Cell Institute Cambridge UK; Department of Haematology University of Cambridge Cambridge UK; Department of Haematology Addenbrooke's Hospital Cambridge UK Correspondence: Elisabeth P. Nacheva, University of Cambridge, Department of Haematology, Cambridge Institute of Medical Research, Hills Rd, Cambridge, CB2 2XY, United Kingdom; e-mail: Wellcome MRC Cambridge Stem Cell Institute University of Cambridge Hills Road Cambridge CB2 0XY United Kingdom; Department of Hematology University of Cambridge CB2 0XY United Kingdom; Department of Hematology Cambridge University Hospitals NHS Foundation Trust Hills Road Cambridge CB2 0QQ United Kingdom Cambridge University Department of Haematology, Cambridge Institute for Medical Research, Hills Road, Cambridge, CB2 2XY, UK. Cambridge Institute for Medical Research and Wellcome Trust/Medical Research Council, Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, United Kingdom Department of Haematology, Addenbrooke’s Hospital, Cambridge, United Kingdom Department of Haematology, Cambridge Institute for Medical Research, Cambridge, United Kingdom; From the Department of Hematology, University of Cambridge, Cambridge Institute for Medical Research, United Kingdom; and Harvard Institute of Human Genetics, Harvard Institute of Medicine, Boston, MA. Cambridge Institute for Medical Research Cambridge UK Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom;; Department of Haematology, University of Cambridge, Cambridge, United Kingdom; Department of Haematology, Addenbrooke's Hospital, Cambridge, UK. From the Department of Hematology, Cambridge Institute for Medical Research, University of Cambridge, United Kingdom. Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom;; Department of Haematology, University of Cambridge, Cambridge, United Kingdom; Department of Haematology, Cambridge Institute for Medical Research & Wellcome Trust and MRC Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom Department of Haematology, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom; and; Cambridge University Foundation Hospital Trust, Cambridge, United Kingdom Cambridge Institute for Medical Research and Department of Haematology, University of Cambridge, and Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom; University of Cambridge, Department of Haematology, CIMR Centre, Hills Road, Cambridge CB2 2XY, UK Department of Haematology, University of Cambridge, Cambridge, United Kingdom Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 2XY, United Kingdom; Cambridge Institute for Medical Research and Department of Haematology, University of Cambridge; and Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom From the Department of Hematology and the Applied Medical Statistics Department, University of Cambridge, United Kingdom; Victorian Cancer Cytogenetic Service, St Vincent Hospital, Fitzroy, Australia; the Department of Hematology, City Hospital, Nottingham, United Kingdom; the Department of Hematology, University Hospital, Poitiers, France; and the Department of Hematology, University Hospital, Leipzig, Germany. Department of Haematology, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom;; Cambridge University Foundation Hospital Trust, Cambridge, United Kingdom; and Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA 02142; Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research, Cambridge, MA 02142; Cambridge Institute for Medical Research, Cambridge University, Hills Road, Cambridge CB2 2XY, United Kingdom; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142; Department of Pediatric Oncology, Dana–Farber Cancer Institute, Boston, MA 02115; Harvard Medical School, Boston,... Department of Haematology, Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, United Kingdom; and; Department of Haematology, Addenbrooke’s Hospital, Cambridge, United Kingdom University of Cambridge Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge CB2 2XY, United Kingdom; and Department of Anatomy, University of Cambridge, Downing Street, Cambridge CB2 3DY, United Kingdom Anna L. Godfrey, Jacob Grinfeld, and Anthony R. Green, Cambridge University Hospitals National Health Service (NHS) Foundation Trust; Peter J. Campbell and Jyoti Nangalia, Wellcome Trust Sanger Institute, Hinxton; Cathy MacLean, Julia Cook, Julie Temple, and Anthony R. Green, University of Cambridge; Anthony R. Green, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge; Georgina Buck, University of Oxford, Oxford; Bridget S. Wilkins and Claire N. Harrison, Guy’s and St... Cambridge Institute for Medical Research and; Department of Haematology, University of Cambridge, Cambridge, United Kingdom;; Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom; and Department of Haematology, Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, United Kingdom;; Department of Haematology, Addenbrooke's Hospital, Cambridge CB2 2QR, United Kingdom From the Division of Cancer Biology, Telethon Institute for Child Health Research, Centre for Child Health Research and Western Australian Institute for Medical Research (WAIMR), University of Western Australia, West Perth, WA, Australia; Rotary Bone Marrow Research Laboratory, Royal Melbourne Hospital, Parkville, Victoria, Australia; and The University of Cambridge, Department of Haematology, Cambridge Institute for Medical Research, Cambridge, United Kingdom. 1Wellcome–Medical Research Council Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge, United Kingdom; 2Department of Haematology, University of Cambridge, Cambridge, United Kingdom Department of Haematology Cambridge Institute for Medical Research Cambridge UK Department of Hematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom; Cambridge Institute for Medical Research and Wellcome Trust/Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom;; Department of Haematology, University of Cambridge, United Kingdom;; Department of Haematology, Addenbrooke’s Hospital, Cambridge, United Kingdom; *Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; Department of Haematology, University of Cambridge, Cambridge, United Kingdom Cambridge Institute for Medical Research and Wellcome Trust/Medical Research Council Stem Cell Institute and; Department of Haematology, University of Cambridge, Cambridge, United Kingdom;; Department of Haematology, Addenbrooke’s Hospital, Cambridge, United Kingdom; Univeristy of Cambridge Cambridge UK From the Department of Haematology, University of Cambridge; Departments of Haematology and Histopathology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton; Department of Haematology, Russells Hall Hospital, Dudley; Birmingham Clinical Trials Unit, University of Birmingham, Birmingham; Departments of Histopathology and Haematology, St Thomas' Hospital, London; and the Clinical Trial Service Unit, Oxford,... Wellcome–MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom;; Department of Haematology, University of Cambridge, Cambridge, United Kingdom;; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; and; Cambridge Institute for Medical Research, Cambridge, United Kingdom Department of Haematology, University of Cambridge, Cambridge CB2 2XY, United Kingdom; and Cambridge Institute for Medical Research and Wellcome Trust/Medical Research Council, Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, United Kingdom; Department of Haematology, Addenbrooke’s Hospital, Cambridge, United Kingdom University of Cambridge, Cambridge, United Kingdom Department of Haematology, Cambridge Institute for Medical Research, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom; and Cambridge Institute for Medical Research,; Medical Research Council/Wellcome Trust Cambridge Stem Cell Institute, and; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, United Kingdom;; Department of Haematology, Addenbrooke’s Hospital, Cambridge CB2 0XY, United Kingdom; and From the Department of Haematology, Cambridge Institute for Medical Research, Cambridge University, Cambridge, United Kingdom. Department of Hematology, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, United Kingdom; Cambridge Institute for Medical Research and Department of Haematology, University of Cambridge, Cambridge, United Kingdom;; Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom; Wellcome‐MRC Cambridge Stem Cell Institute Cambridge United Kingdom; Department of Haematology Addenbrooke's Hospital Cambridge United Kingdom; Department of Haematology University of Cambridge Cambridge United Kingdom Cambridge Institute for Medical Research and Department of Haematology, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 0QQ, UK Cambridge Institute for Medical Research and Department of Haematology, University of Cambridge, Cambridge, United Kingdom;; Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom;; Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom; Department of Haematology, University of Cambridge, Cambridge, United Kingdom;; Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom; Department of Haematology, Cambridge Institute for Medical Research, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom Department of Haematology, Cambridge Institute for Medical Research, Cambridge University, United Kingdom; From the Division of Cancer Biology, Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, West Perth, Australia; Rotary Bone Marrow Research Laboratory, Royal Melbourne Hospital, Parkville, Victoria, Australia; and The University of Cambridge, Department of Haematology, Cambridge Institute for Medical Research, Cambridge, United Kingdom. From the Walter and Eliza Hall Institute of Medical Research and the Rotary Bone Marrow Research Laboratories, Royal Melbourne Hospital, Parkville, Victoria, Australia; and the Department of Haematology, University of Cambridge, Cambridge UK. Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 2XY, United Kingdom Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute Department of Haematology University of Cambridge Cambridge United Kingdom; Department of Haematology Addenbrooke's Hospital Cambridge United Kingdom From the Department of Haematology, Cambridge Institute for Medical Research; and the Department of Haematology, Addenbrooke's National Health Service (NHS) Trust, Cambridge, United Kingdom. Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, United Kingdom; From the Department of Hematology/Oncology, Harvard Institutes of Medicine, Harvard Medical School, Boston, MA; Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, United Kingdom; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Pathology, Brigham and Women's Hospital, Boston, MA; and Blood Center of South Eastern Wisconsin, Milwaukee. Department of Haematology, University of Cambridge, Cambridge, United Kingdom; |
Incoming Links
Showing number of triples: 1 to 310 of 310.